BIOMAT Database Logo BIOMAT Database Logo

[Treatment of lung cancer with Endoxan, with reference to the effect of massive intermittent administration]. 1967

M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Experiences in intermittent massive administration of endoxan for malignant bone tumors, with special reference to osteosarcoma].
May 1969, Seikeigeka. Orthopedic surgery,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Case of lung carcinoma treated with massive intravenous administration of Endoxan].
May 1971, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Experience with Endoxan massive treatment].
November 1966, Saishin igaku. Modern medicine,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Chemotherapy of stomach cancer-with special reference to massive and intermittent administration of mitomycin C].
June 1966, Naika. Internal medicine,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[OBSERVATIONS ON THE TREATMENT OF LUNG CANCER WITH ENDOXAN].
March 1964, Die Medizinische Welt,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Chemotherapy of lung cancer with special reference to combined therapy with mitomycin and endoxan].
May 1966, Gan no rinsho. Japan journal of cancer clinics,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
Massive (Atelectatic) Collapse of Lung With Especial Reference to Treatment.
July 1927, Canadian Medical Association journal,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Chemotherapy of malignant tumors using massive-dose administration of Endoxan].
October 1967, Munchener medizinische Wochenschrift (1950),
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Studies on the administration of massive doses of endoxan in pulmonary neoplasms].
March 1969, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
M Matsuda, and H Nishihara, and T Komatsu, and S Hattori, and T Terasawa
[Results of the treatment of ovarian cancer with Endoxan].
July 1962, Medizinische Klinik,
Copied contents to your clipboard!